DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Piotrowski DW. * et al. Pfizer Worldwide Research & Development, Groton, USA
PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease.
J. Med. Chem. 2021;
64: 326-342
DOI: 10.1021/acs.jmedchem.0c01518.
We do not assume any responsibility for the contents of the web pages of other providers.